title: Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure.
abstract: OBJECTIVE
  Beta-adrenergic receptor antagonists (beta-antagonists) have long been used to control perioperative tachyarrhythmias. The effects of a beta(1)-antagonist, landiolol, on perioperative hemodynamics are unknown. We aimed to determine the appropriate dosage of landiolol for the treatment of hemodynamic changes in response to endotracheal intubation.
  
  
  METHODS
  Sixty-four patients without heart disease or hypertension, were assigned to receive saline (group C) or landiolol (0.1 or 0.3 mg.kg(-1); groups L1 and L3). Anesthesia was induced with propofol (2 mg.kg(-1) iv) followed by saline or landiolol iv. After ventilation with facemask using 2% sevoflurane in 100% oxygen for 90 sec, endotracheal intubation was performed. After intubation, anesthesia was maintained using 1% sevoflurane in combination with 50% nitrous oxide. Values of heart rate and mean arterial blood pressure were recorded before induction to five minutes after intubation.
  
  
  RESULTS
  In group C, heart rate and mean blood pressure increased simultaneously after tracheal intubation, compared with baseline values. Heart rate values were attenuated immediately before as well as after intubation in group L3, compared with groups C and L1. Heart rate did not increase after tracheal intubation in group L1, compared with baseline. In contrast, mean arterial blood pressure values did not differ among groups.
  
  
  CONCLUSIONS
  The newly developed beta(1)-antagonist landiolol (0.1 and 0.3 mg.kg(-1)) may help prevent tachycardia without affecting blood pressure during the induction of anesthesia.
authors.affiliation: Department of Anesthesia, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan.
authors.forename: Akinori
authors.initials: A
authors.lastname: Yamazaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kinoshita
authors.forename: Manabu
authors.initials: M
authors.lastname: Shimogai
authors.forename: Keisuke
authors.initials: K
authors.lastname: Fujii
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Nakahata
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Hironaka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Iranami
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Hatano
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects*; D004311:Double-Blind Method; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007442:Intubation, Intratracheal; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology*; D014508:Urea / Q000031:analogs & derivatives* / Q000494:pharmacology*
chemical_list: D000319:Adrenergic beta-Antagonists; D009025:Morpholines; C077049:landiolol; D014508:Urea